iHeart Japan Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $5.43M

  • Investors
  • 14

iHeart Japan General Information

Description

Developer of a cardiac regenerative medicinal product created to release patients from waiting for heart transplantation and to make it accepted broadly. The company provides a product that utilizes cell differentiation induction technology to attach a cell sheet to the heart to create a vascular network with blood circulation to bring better therapeutic effects and also provides healthcare contract and consulting services, enabling physicians to restore cardiac function as well as other organs such as the liver.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Creation Core Kyoto Gosha 310
  • 448-5 Kajii-cho, Kamigyo -ku
  • Kyoto, 604-8221
  • Japan
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Creation Core Kyoto Gosha 310
  • 448-5 Kajii-cho, Kamigyo -ku
  • Kyoto, 604-8221
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iHeart Japan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 01-Sep-2025 $5.43M Completed Clinical Trials - Phase 2
5. Accelerator/Incubator 20-Oct-2021 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 06-Jul-2021 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 19-May-2016 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 01-Jan-2015 $2M Completed Startup
1. Seed Round 01-Sep-2014 $2M $2M Completed Startup
To view iHeart Japan’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

iHeart Japan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cardiac regenerative medicinal product created to release patients from waiting for heart transplantation
Drug Discovery
Kyoto, Japan
16 As of 2026

Lexington, MA
 

Berlin, Germany
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iHeart Japan Competitors (42)

One of iHeart Japan’s 42 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Pramomolecular Accelerator/Incubator Backed Berlin, Germany
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Metcela Venture Capital-Backed Kawasaki, Japan
Histogen Formerly VC-backed San Ramon, CA
You’re viewing 5 of 42 competitors. Get the full list »

iHeart Japan Patents

iHeart Japan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019024325-A Method for freezing human pluripotent stem cell-derived cardiomyocytes Active 25-Jul-2017
JP-6973731-B2 Method of freezing human pluripotent stem cell-derived cardiomyocytes Active 25-Jul-2017
JP-2017108705-A Cardiomyocyte production method Pending 18-Dec-2015
JP-5924750-B2 Cd82 positive myocardial progenitor cells Active 01-May-2014
JP-WO2015166638-A1 Cd82 positive myocardial progenitor cells Active 01-May-2014 C12N5/0657
To view iHeart Japan’s complete patent history, request access »

iHeart Japan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iHeart Japan Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mitsui Sumitomo Kaijo Capital Corporate Venture Capital Minority
J-Startup Accelerator/Incubator
Japan Asia Investment PE/Buyout Minority
Kiyo Capital Management Venture Capital Minority
Kyogin Lease Capital Corporate Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

iHeart Japan FAQs

  • When was iHeart Japan founded?

    iHeart Japan was founded in 2013.

  • Where is iHeart Japan headquartered?

    iHeart Japan is headquartered in Kyoto, Japan.

  • What is the size of iHeart Japan?

    iHeart Japan has 16 total employees.

  • What industry is iHeart Japan in?

    iHeart Japan’s primary industry is Drug Discovery.

  • Is iHeart Japan a private or public company?

    iHeart Japan is a Private company.

  • What is the current valuation of iHeart Japan?

    The current valuation of iHeart Japan is .

  • What is iHeart Japan’s current revenue?

    The current revenue for iHeart Japan is .

  • How much funding has iHeart Japan raised over time?

    iHeart Japan has raised $21.1M.

  • Who are iHeart Japan’s investors?

    Mitsui Sumitomo Kaijo Capital, J-Startup, Japan Asia Investment, Kiyo Capital Management, and Kyogin Lease Capital are 5 of 14 investors who have invested in iHeart Japan.

  • Who are iHeart Japan’s competitors?

    Voyager Therapeutics, Pramomolecular, Cellaion, Metcela, and Histogen are some of the 42 competitors of iHeart Japan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process